WASHINGTON, DC — A new consensus statement released this week by the Heart Rhythm Society (HRS) and nine other medical societies provides physicians practical clinical advice on cardiac implantable ...
COLORADO SPRINGS, Colo., The Spectranetics Corporation today announced U.S. Food and Drug Administration (FDA) Premarket Notification 510(k) submission of the Bridge Occlusion Balloon. Building on the ...
Infections associated with pacemaker or implantable defibrillator systems, even when limited to the subcutaneous pocket, generally call for removal of the pulse-generator and leads. But alternative ...
Roughly one out of every five patients with an implantable device who is undergoing lead extraction will have incidental thrombi found on the transvenous leads, new prospective data show. The clots ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results